CN116585217A - Retinol wrap, raw material and external skin preparation easier to be absorbed through skin - Google Patents
Retinol wrap, raw material and external skin preparation easier to be absorbed through skin Download PDFInfo
- Publication number
- CN116585217A CN116585217A CN202310870369.7A CN202310870369A CN116585217A CN 116585217 A CN116585217 A CN 116585217A CN 202310870369 A CN202310870369 A CN 202310870369A CN 116585217 A CN116585217 A CN 116585217A
- Authority
- CN
- China
- Prior art keywords
- retinol
- wrap
- matrine
- solvent
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 title claims abstract description 275
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 title claims abstract description 140
- 229960003471 retinol Drugs 0.000 title claims abstract description 139
- 235000020944 retinol Nutrition 0.000 title claims abstract description 139
- 239000011607 retinol Substances 0.000 title claims abstract description 139
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000002994 raw material Substances 0.000 title claims abstract description 16
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 claims abstract description 54
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 claims abstract description 54
- 229930014456 matrine Natural products 0.000 claims abstract description 54
- 239000002904 solvent Substances 0.000 claims abstract description 50
- 238000003756 stirring Methods 0.000 claims description 21
- 239000003963 antioxidant agent Substances 0.000 claims description 17
- 235000006708 antioxidants Nutrition 0.000 claims description 17
- 239000003240 coconut oil Substances 0.000 claims description 17
- 239000002537 cosmetic Substances 0.000 claims description 16
- 235000019864 coconut oil Nutrition 0.000 claims description 15
- 239000003921 oil Substances 0.000 claims description 15
- 235000019198 oils Nutrition 0.000 claims description 15
- 230000003078 antioxidant effect Effects 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 13
- 239000002608 ionic liquid Substances 0.000 claims description 13
- 241000727169 Prinsepia utilis Species 0.000 claims description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 235000010384 tocopherol Nutrition 0.000 claims description 10
- 239000011732 tocopherol Substances 0.000 claims description 10
- 229930003799 tocopherol Natural products 0.000 claims description 10
- 229960001295 tocopherol Drugs 0.000 claims description 10
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 9
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 9
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 9
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 9
- 244000170916 Paeonia officinalis Species 0.000 claims description 9
- 239000010466 nut oil Substances 0.000 claims description 9
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 9
- 239000012298 atmosphere Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000001228 spectrum Methods 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 3
- 230000007794 irritation Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 24
- 229920001577 copolymer Polymers 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000003755 preservative agent Substances 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- -1 masks Substances 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 125000002523 retinol group Chemical group 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940048053 acrylate Drugs 0.000 description 2
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- YHHHHJCAVQSFMJ-FNORWQNLSA-N (3e)-deca-1,3-diene Chemical compound CCCCCC\C=C\C=C YHHHHJCAVQSFMJ-FNORWQNLSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VUWCWMOCWKCZTA-UHFFFAOYSA-N 1,2-thiazol-4-one Chemical class O=C1CSN=C1 VUWCWMOCWKCZTA-UHFFFAOYSA-N 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N 1,4-Benzenediol Natural products OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- 235000001553 Betula platyphylla Nutrition 0.000 description 1
- 241001313086 Betula platyphylla Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- JYZSBRXMWUUVSP-UHFFFAOYSA-N C(CC(=O)OCCCCCCCCCCCC)(=S)OCCCCCCCCCCCC Chemical compound C(CC(=O)OCCCCCCCCCCCC)(=S)OCCCCCCCCCCCC JYZSBRXMWUUVSP-UHFFFAOYSA-N 0.000 description 1
- OXJGJKIURHREKH-UHFFFAOYSA-O CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C Chemical compound CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C OXJGJKIURHREKH-UHFFFAOYSA-O 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- QCZAWDGAVJMPTA-RNFRBKRXSA-N ClC1=CC=CC(=N1)C1=NC(=NC(=N1)N[C@@H](C(F)(F)F)C)N[C@@H](C(F)(F)F)C Chemical compound ClC1=CC=CC(=N1)C1=NC(=NC(=N1)N[C@@H](C(F)(F)F)C)N[C@@H](C(F)(F)F)C QCZAWDGAVJMPTA-RNFRBKRXSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000164480 Curcuma aromatica Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005058 Isophorone diisocyanate Substances 0.000 description 1
- 239000002310 Isopropyl citrate Substances 0.000 description 1
- XBLJCYOUYPSETL-UHFFFAOYSA-N Isopropyl citrate Chemical compound CC(C)O.CC(=O)CC(O)(C(O)=O)CC(O)=O XBLJCYOUYPSETL-UHFFFAOYSA-N 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical class CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- VQENOYXMFIFHCY-UHFFFAOYSA-N Monoglyceride citrate Chemical compound OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O VQENOYXMFIFHCY-UHFFFAOYSA-N 0.000 description 1
- KFLQGJQSLUYUBF-PMACEKPBSA-N Phyllanthin Natural products C([C@@H](COC)[C@H](COC)CC=1C=C(OC)C(OC)=CC=1)C1=CC=C(OC)C(OC)=C1 KFLQGJQSLUYUBF-PMACEKPBSA-N 0.000 description 1
- KFLQGJQSLUYUBF-WOJBJXKFSA-N Phyllanthin Chemical compound C([C@H](COC)[C@@H](COC)CC=1C=C(OC)C(OC)=CC=1)C1=CC=C(OC)C(OC)=C1 KFLQGJQSLUYUBF-WOJBJXKFSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000004978 Rosa x damascena Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Chemical class 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- AQKOHYMKBUOXEB-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-(16-methylheptadecanoyloxy)oxolan-2-yl]-2-(16-methylheptadecanoyloxy)ethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC(C)C)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCC(C)C AQKOHYMKBUOXEB-RYNSOKOISA-N 0.000 description 1
- OCKWAZCWKSMKNC-UHFFFAOYSA-N [3-octadecanoyloxy-2,2-bis(octadecanoyloxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC OCKWAZCWKSMKNC-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 1
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000012164 animal wax Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- GADGVXXJJXQRSA-UHFFFAOYSA-N ethenyl 8-methylnonanoate Chemical compound CC(C)CCCCCCC(=O)OC=C GADGVXXJJXQRSA-UHFFFAOYSA-N 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000009609 fructus phyllanthi Substances 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 125000000687 hydroquinonyl group Chemical group C1(O)=C(C=C(O)C=C1)* 0.000 description 1
- 229940031575 hydroxyethyl urea Drugs 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 235000019300 isopropyl citrate Nutrition 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 229960003951 masoprocol Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000010387 octyl gallate Nutrition 0.000 description 1
- 239000000574 octyl gallate Substances 0.000 description 1
- NRPKURNSADTHLJ-UHFFFAOYSA-N octyl gallate Chemical compound CCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 NRPKURNSADTHLJ-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002553 poly(2-methacrylolyloxyethyltrimethylammonium chloride) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 229940001607 sodium bisulfite Drugs 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical class [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940100459 steareth-20 Drugs 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000005672 tetraenes Chemical class 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The application provides a retinol wrap, a raw material and an external skin preparation which are easier to be absorbed through skin, wherein the retinol wrap at least comprises the following components: retinol; matrine and solvent; intermolecular forces exist between the retinol and matrine. The retinol wrap disclosed by the application is not easy to separate out, has a stable and ordered structure and good stability, can protect the bioactivity of retinol while reducing the irritation of retinol, and can exert the maximum efficacy of retinol.
Description
Technical Field
The application relates to the field of cosmetics, in particular to a retinol wrap, a raw material and an external skin preparation which are easier to be absorbed through skin.
Background
Vitamin a includes two subtypes: VA-1 (retinol) and VA-2 (retinol and retinoic acid), retinol and retinol esters (retinol esters prepared by chemical reaction of vitamin A) are widely applied to anti-aging and anti-wrinkle products in recent years, and the effect is remarkable. Retinol is a fat-soluble alcohol substance, can regulate metabolism of epidermis and cutin, can reduce seborrhea, lighten pigment color spots, stimulate collagen production, reduce wrinkles, improve relaxation, help skin recover elasticity and smoothness, and is widely applied to anti-aging and anti-wrinkle products in recent years. Products in the cosmetic market are therefore based on the addition of retinol.
However, retinol and its derivatives are inferior in stability and easily degraded under ultraviolet, air, photo-thermal conditions, etc., because the side chain of the tetraene of retinol is particularly easily receiving energy of light waves, and ultraviolet rays easily transfer energy to it, so that the structure of the retinol is changed to lose bioactivity. In general, retinol palmitate is more stable than retinol but is thermodynamically unstable, and studies have shown that 2% of retinol palmitate degrades by 38% in an oil-in-water system at 4 ℃ for 7 days.
Disclosure of Invention
The application aims to solve the technical problems:
how to improve the stability of retinol.
The technical means for solving the technical problems are as follows:
through repeated researches, the inventor finds that the retinol coating can form an ordered structure after being mixed with matrine and a solvent, and has excellent stability. In addition, the retinol wrap has higher transdermal rate, and retinol can penetrate into the bottom layer of the skin to enable the skin to absorb better. The active loss of retinol after three weeks at 50 ℃ was only 4.2%.
In one aspect of the present application, there is provided a retinol wrap characterized in that it comprises at least: retinol; matrine; a solvent; intermolecular forces exist between the retinol and matrine.
In one aspect of the present application, a retinol wrap is provided, which comprises at least retinol; matrine; a solvent; the retinol wrap has at least the following hydrogen signals in the nuclear orvehaus effect spectrum:
(3.71-3.74,2.00-2.04) or (2.00-2.04,3.71-3.74);
(4.20-4.22,1.55-1.58) or (1.55-1.58,4.20-4.22);
(3.71-3.75,1.53-1.56) or (1.53-1.56,3.71-3.75).
In one aspect of the present application, there is provided the use of the aforementioned retinol wrap for the preparation of cosmetics or skin care products.
In one aspect of the present application, a cosmetic raw material is provided that includes at least the aforementioned retinol wrap.
In one aspect of the present application, there is provided a skin preparation for external use comprising at least the aforementioned retinol wrap.
In one aspect of the present application, a method for preparing a retinol wrap is provided, which is characterized by providing retinol, matrine, solvent and antioxidant;
mixing, heating and stirring matrine and a solvent under a light-shielding condition and an inert atmosphere, wherein the heating temperature is 40-60 ℃, the stirring speed is 600-750 r/min, and reacting for 2-4 hours to obtain an ionic liquid;
mixing and stirring retinol and the ionic liquid cooled to normal temperature under the light-shielding condition and inert atmosphere, wherein the stirring speed is 600-750 r/min, and stirring for 2-4 hours to obtain a primary liquid;
mixing the antioxidant with the primary liquid, and stirring for 0.5-1 h at a stirring speed of 600-750 r/min to obtain the retinol wrap. The beneficial effects are that:
the retinol wrap disclosed by the application is not easy to separate out, has a stable and ordered structure and good stability, and can protect the bioactivity of retinol while reducing the irritation of retinol.
The retinol wrap of the present application is well dissolved in the aqueous phase of cosmetics and is substantially unaffected by dissolved oxygen in water.
The retinol wrap disclosed by the application has good permeability, can assist retinol to penetrate into the bottom layer of skin, and can be better absorbed by skin to exert an excellent anti-aging effect.
Drawings
The application also provides a drawing related to the technical scheme provided for explaining the technical scheme of the application. The drawings and description are only for the purpose of illustrating the application more clearly and should not be taken as limiting the scope of the application as claimed.
FIG. 1 is a state diagram of the combination of retinol with different alkaloids and solvents, wherein sample (1) comprises retinol, betaine and malic acid, sample (2) comprises retinol, betaine and glycerol, sample (3) comprises retinol, L-carnitine and succinic acid, sample (4) comprises retinol, L-carnitine and BAIHUA seed oil, sample (5) comprises retinol, matrine and coconut oil, sample (6) comprises retinol, matrine and camellia seed oil, and sample (7) comprises retinol, matrine and prinsepia utilis royle oil; the retinol content in samples (1) to (7) was 10%;
fig. 2 is a state diagram of the samples (1) to (7) (2%) in fig. 1 after mixing with water (98%).
FIG. 3 is a two-dimensional nuclear magnetic pattern test result of the retinol wrap of the present application;
FIG. 4 is a graphical representation of the statistics of the relative amount of active in a retinol wrap according to the present application over time at various temperature conditions;
FIG. 5 is a graph showing the results of a transdermal test of a retinol wrap of the present application with a conventional retinol solution;
fig. 6 shows a retinol wrap prepared using different solvents, and in fig. 6, examples 5, 6, 7 and 8 are shown in order from the left.
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the embodiments of the present application more clear, the technical solutions of the embodiments of the present application will be clearly and completely described below, and it is obvious that the described embodiments are not all embodiments.
Elements and features described in one embodiment of the application may be combined with elements and features shown in one or more other embodiments. It should be noted that the illustration and description of components and processes known to those of ordinary skill in the art, which are not relevant to the present application, have been omitted for clarity.
Definition of the definition
Herein, unless otherwise indicated, the term "%" means "% by mass".
Herein, unless otherwise indicated, the term "%" herein refers to based on the total mass of the composition of the present application.
In this context, all ranges defined refer to: including each specific range within a given range as well as combinations of sub-ranges between the given ranges. For example, a range of 1 to 5 specifically includes 1, 2,3, 4 and 5, and also includes sub-ranges such as 2 to 5,3 to 5, 2 to 3,2 to 4,1 to 4, etc.
In this context, the range of ratios refers to: including each specific ratio within a given range and combinations of sub-ranges between the given ranges.
In this context, "intermolecular forces" include both weak electrostatic interactions caused by the permanent and momentary dipoles of the molecules, and hydrogen bonds. The intermolecular force can be determined by detecting whether a nuclear European Haohaus effect (Nuclear Overhauser Effect, NOE) exists between retinol and an ionic liquid consisting of matrine and coconut oil through a two-dimensional nuclear magnetic NOESY spectrogram.
Herein, the cosmetic raw material means any one or more forms commonly used in the field of skin care products or cosmetics including powdery raw materials, colloidal raw materials, oily raw materials, solvent raw materials, and the like, which can be employed without affecting the technical effects of the formulation of the present application.
Herein, the external skin preparation means any one or more forms commonly used in the field of skin care products or cosmetics including lotions, emulsions, foundations, hand creams, lotions, shampoos, conditioners, hair conditioners, styling agents, masks, soaps, facial washes and the like, which can be employed without affecting the technical effects of the preparation of the present application.
The application is that
The present application provides a retinol wrap comprising at least:
retinol;
matrine;
a solvent;
intermolecular forces exist between the retinol and matrine.
The present application also provides a retinol wrap comprising at least:
retinol;
matrine;
a solvent;
the retinol wrap has at least the following hydrogen signals in the nuclear orvehaus effect spectrum:
(3.71-3.74,2.00-2.04) or (2.00-2.04,3.71-3.74);
(4.20-4.22,1.55-1.58) or (1.55-1.58,4.20-4.22);
(3.71-3.75,1.53-1.56) or (1.53-1.56,3.71-3.75).
Optionally, the retinol wrap has at least the following hydrogen signals in the nuclear orvehaus effect spectrum:
(3.72-3.73,2.01-2.02) or (2.01-2.02,3.72-3.73);
(4.20-4.21,1.55-1.56) or (1.55-1.56,4.20);
(3.73-3.74,1.54-1.55) or (1.54-1.55,3.73-3.74).
Optionally, the solvent is at least one of coconut oil, peony seed oil, macadamia nut oil and prinsepia utilis royle oil.
Optionally, the solvent is at least one of coconut oil and prinsepia utilis royle oil.
Optionally, the retinol content is 0.01-15%.
Optionally, the matrine content is 25-60%, and the solvent content is 25-60%.
Optionally, the content ratio of matrine to solvent is 1:0.5-1.5.
Optionally, an antioxidant is also included, and the antioxidant is at least one of tocopherol, ascorbic acid and dibutyl hydroxy toluene.
The application also provides the use of any of the foregoing retinol wraps for the preparation of cosmetics or skin care products.
The application also provides a raw material for cosmetics, which at least comprises any one of the retinol wrappers.
The application also provides an external skin preparation which at least comprises any one of the retinol wrappers.
The application also provides a preparation method of the retinol wrap, which comprises the following steps:
providing retinol, matrine, a solvent and an antioxidant;
mixing, heating and stirring matrine and a solvent under a light-shielding condition and an inert atmosphere, and reacting for 2-4 hours to obtain an ionic liquid;
mixing and stirring retinol and the ionic liquid cooled to normal temperature for 2-4 hours under a light-shielding condition and an inert atmosphere to obtain a primary liquid;
mixing and stirring the antioxidant and the primary liquid for 0.5-1 h to obtain the retinol wrap.
Optionally, the solvent is at least one of coconut oil, peony seed oil, macadamia nut oil and prinsepia utilis royle oil.
Retinol wrap
The present application provides a retinol wrap comprising at least: retinol; matrine; a solvent; intermolecular forces exist between the retinol and matrine.
The ionic liquid composed of matrine and a proper solvent has good suitability with retinol, and retinol is fully dissolved in the ionic liquid without precipitation, and has good solubility and no turbidity after being mixed with water, as shown in figures 1 and 2.
The solvent is preferably selected from any one or more of coconut oil, peony seed oil, macadamia nut oil, prinsepia utilis royle oil. Through tests, when the solvent is prepared into coconut oil, peony seed oil, macadamia nut oil and prinsepia utilis royle oil, the retinol wrapping material has transparent appearance, good uniformity and full dissolution after being mixed with the aqueous solution.
The retinol content is preferably 0.01 to 15%. As a further preferred, the retinol content is preferably 0.01 to 12%. As a further preferred, the retinol content is preferably 0.01 to 10%. For example, specifically, the content of retinol is preferably 0.1 to 1%, or preferably 2%, or preferably 3%, or preferably 4%, or preferably 5%, or preferably 6%, or preferably 7%, or preferably 8%, or preferably 9%, or preferably 10%.
The matrine content is preferably 25-60%. Further preferably, the matrine content is 45-55%. Specifically, the content of matrine is preferably 25 to 30%, or preferably 30 to 35%, or preferably 35 to 40%, or preferably 40 to 45%, or preferably 45 to 50%, or preferably 50 to 55%, or preferably 55 to 60%.
The solvent is preferably selected from any one of coconut oil, peony seed oil, macadamia nut oil, prinsepia utilis royle oil. When the solvent is coconut oil, peony seed oil, macadamia nut oil and prinsepia utilis royle oil, the retinol wrap is more stable, and the problems of color change, layering, water dissolution and the like are not easy to occur. The content of the solvent is preferably 25 to 60%. Further preferably, the matrine content is 45-55%. Specifically, the content of matrine is preferably 25 to 30%, or preferably 30 to 35%, or preferably 35 to 40%, or preferably 40 to 45%, or preferably 45 to 50%, or preferably 50 to 55%, or preferably 55 to 60%.
Preferably, the content ratio of matrine to solvent is 1:0.5-1.5. Further preferably, the content ratio of matrine to solvent is 1:0.8-1.2. For example, specifically, the content ratio of matrine to solvent is 1:0.5, or the content ratio of matrine to solvent is 1:0.6, or the content ratio of matrine to solvent is 1:0.7, or the content ratio of matrine to solvent is 1:0.8, or the content ratio of matrine to solvent is 1:0.9, or the content ratio of matrine to solvent is 1:1, or the content ratio of matrine to solvent is 1:1.1, or the content ratio of matrine to solvent is 1:1.2, or the content ratio of matrine to solvent is 1:1.3, or the content ratio of matrine to solvent is 1:1.4, or the content ratio of matrine to solvent is 1:1.5. When the content ratio of matrine to solvent is 1:0.8-1.2, more retinol can be dissolved in the retinol wrap.
Antioxidants may preferably be included in the retinol wrap in an amount of 0.01 to 10%. Further preferably, the content of the antioxidant is 0.01 to 5%. The antioxidant may be selected from commonly used antioxidants such as vitamin C, tocopherol, dibutyl hydroxytoluene, etc., preferably the antioxidant is tocopherol.
Raw material for cosmetics or external skin preparation
The application also provides a raw material for cosmetics or an external skin preparation, wherein the raw material for cosmetics or the external skin preparation can comprise other functional substances besides retinol inclusion, and the raw material for cosmetics or the external skin preparation comprises at least one of skin conditioning agents, antioxidants, lipids, thickening agents, emulsifying agents, moisturizers, preservatives, solubilizers, chelating agents and essence.
In the composition of the present application, the skin conditioner is not particularly limited. The skin conditioner is selected from hydroquinone, kojic acid, arbutin, ellagic acid, azelaic acid, L-ascorbic acid and its derivatives, glycyrrhrizae radix extract, fructus Polygoni Tinctorii extract, hydrangea extract, alkoxysalicylic acid, rhizoma Polygoni Cuspidati extract, flos Sophorae Immaturus extract, curcuma rhizome extract, cortex Mori extract, fructus Phyllanthi extract, semen Pisi Sativi extract, aloin, etc.
The antioxidant is not particularly limited in the present application. The antioxidant may be selected from butylhydroxytoluene, butylhydroxyanisole, propyl gallate, octyl gallate, dodecanol gallate, tertiary butylhydroquinone, tocopherol, ascorbyl palmitate, a mixture of isopropyl citrate, monoglyceride citrate, canola, sodium sulfite, sodium bisulfite, sodium metabisulfite, cysteine, isoascorbic acid, thiourea, dilauryl thiomalonate, nordihydroguaiaretic acid, lipoic acid, alpha-tocopheryl acetate, carotenoids, phyllanthin, ascorbic acid, glutathione, coenzyme Q10, and the like.
The lipid is not particularly limited in the present application. The lipid is selected from the group consisting of vegetable oils, animal oils, mineral oils, lanolin and derivatives thereof. The lipid can be selected from waxes, such as animal wax, vegetable wax, and mineral wax. The lipid may be selected from fatty acids and fatty alcohols. The lipid may be selected from lipids used to synthesize the skin barrier.
The thickener is not particularly limited in the present application. The thickener is selected from acrylic polymer and its derivatives, carbomer polymer, acrylic acid (ester)/C 10 ~C 30 Alkanol acrylate copolymer, acrylate/C 10 ~C 30 Alkanoacrylate crosslinked copolymer, acrylic acid (ester) copolymer, polyacrylate-1 crosslinked polymer, acrylic acid/acrylamide nitrogen copolymer, acrylic acid (ester) type/steareth (20) methacrylate copolymer, acrylic acid (ester) type/beheneth (25) methacrylate copolymer, acrylic acid (ester) type/steareth-20 itaconate copolymer, acrylic acid (ester) type/aminoacrylate copolymer, acrylic acid (ester) type/vinyl isodecanoate crosslinked polymer, steareth (10) allyl ether/acrylic acid (ester) type copolymer acrylic copolymer sodium salt/mineral oil/PPG-1 tridecyl polyether-6, glycerol polymethacrylate and compound thereof, castor oil/IPDI copolymer, acrylamide copolymer compound, acrylamide/sodium acrylate copolymer compound, sodium/ammonium acryloyldimethyl taurate copolymer and compound thereof, PVM/MA decadiene crosslinked polymer, PEG-150/decyl alcohol/SMDI copolymer, polyquaternium-31 and polyquaternium-37 compound, polyethylene and polyethylene copolymer, polyethylene glycol, polyethylene oxide, PEG-120 methylglucdioleate, PEG-120 sorbitanTriisostearate, polyvinyl alcohol, PEG-150 pentaerythritol tetrastearate, trishydroxystearin, aluminum hydroxide/magnesium stearate, and the like.
The surfactant is not particularly limited in the present application. The surfactant may be an anionic surfactant, a cationic surfactant, a nonionic surfactant, an amphoteric surfactant, a natural surfactant, a fluorosurfactant, or the like.
The humectant is not particularly limited in the present application. The humectant may be selected from glycerin, propylene glycol, butylene glycol, sorbitol polyether-20, amide type humectant, glycerin polyether type humectant, lactic acid and sodium lactate, sodium pyrrolidone carboxylate, hydroxyethyl urea, erythritol, glycerin polyether-5 lactate, sodium hyaluronate, saccharide isomer, D-panthenol, polyethylene glycol, diglycerin, methacryloxyethyl phosphorylcholine, etc.
The preservative is not particularly limited in the present application. The preservative can be selected from the group consisting of hydroxyphenyl esters and salts thereof, formaldehyde and formaldehyde donors, isothiazolinones, phenolic preservatives, acid preservatives, halide preservatives, quaternary ammonium compounds, alcohols, commonly used built preservatives, natural preservatives and the like.
The chelating agent is not particularly limited in the present application. For example, the chelating agent may be selected from ethylenediamine tetraacetic acid and its sodium salts, glycine, citric acid, succinic acid, and the like.
The essence is not particularly limited in the present application. For example, the essence may be sandalwood, jasmine, rose, sweet orange, vanilla essence, etc. The essence can also comprise essential oil, and can be lime peel oil, bitter orange leaf/twig oil, geranium oil, rosa damascena flower oil, etc.
Experimental part
Sample preparation
Adding coconut oil (about 22 g) into a reaction kettle under the dark condition and inert atmosphere, keeping stirring, adding matrine powder (about 22 g), heating and stirring, wherein the heating temperature is 40-60 ℃, the stirring speed is 600-750 r/min, and reacting for 2-4 h to obtain the ionic liquid.
After the matrine-coconut oil ionic liquid is cooled to room temperature (25 ℃), keeping an inert atmosphere and avoiding light, adding retinol (about 5 g) into the matrine-coconut oil ionic liquid, and stirring at the stirring speed of 600-750 r/min for 2-4 h to obtain a primary liquid.
Finally adding tocopherol (vitamin E) (about 2.5 g), stirring for dissolving, wherein the stirring speed is 600-750 r/min, and the stirring time is 0.5-1 h, so as to obtain the retinol wrap.
Sample detection
Two-dimensional nuclear magnetic analysis
And carrying out two-dimensional nuclear magnetic analysis (a two-dimensional nuclear magnetic NOESY spectrogram is shown in figure 3) on the prepared retinol inclusion.
From fig. 3, it can be clearly seen that there is a clear hydrogen signal between retinol and the ionic liquid composed of matrine and coconut oil (see the label in fig. 3), which indicates that there is a clear nuclear euclidean effect (Nuclear Overhauser Effect, NOE), and thus that there is intermolecular forces in the retinol inclusion, which has a more stable structure.
Stability test
The prepared retinol wrap was subjected to stability test, the test contents include sensory test, temperature test and active content test, and the test results are shown in tables 1 to 3 and fig. 4.
TABLE 1
TABLE 2
TABLE 3 Table 3
From the stability test results of tables 1 to 3 and fig. 4, it can be seen that the retinol wrap of the present application has good stability.
Examples 1 to 4 were tested according to the above test methods, the components of examples 1 to 4 are shown in Table 4, and the statistical results are shown in Table 5.
TABLE 4 Table 4
TABLE 5
Transdermal test
Experimental sample
Sample group: 0.1mL of the retinol wrap was taken and formulated into 1mL of retinol wrap (wherein the solvent was the receiving solution).
Control group: a receiving solution containing 0.01g of retinol material (purity 100%) and 1 mL.
Naturally thawing the isolated pigskin preserved in a low temperature refrigerator, soaking in physiological saline for 30 min, drying with filter paper, fixing between two diffusion cells with iron clamp, and adding 7.5 mL acceptor solution (physiological saline: ethanol=1:1) into the acceptor cell of the vertical diffusion cell.
The sample group and the control group of 1mL were slowly injected into the supply cell, respectively, and the upper port was sealed with a sealing film. When the permeation duration was 4, 6, 24 hours, 200. Mu.L of permeate was placed in an EP tube for HPLC on-machine testing. After each sampling, the receiving well was replenished with an equal amount of receiving liquid and the air bubbles in the well were removed. Repeated three times. The on-machine test data were counted and analyzed, and the results are shown in fig. 5.
As shown in FIG. 5, the retinol wrap of the present application has better transdermal property and skin has better absorption effect on the retinol wrap of the present application compared to retinol solution.
Description of the preferred embodiments
Samples of 2% strength retinol wrap (mixed with 98% water) were prepared according to the aforementioned method for preparing retinol wrap of the present application (example 5, example 6, example 7 and example 8). Wherein example 5 is a mixed solution of 2% retinol wrap (composition of retinol wrap is 10% retinol, 40% matrine, 45% coconut oil and 5% tocopherol) with 98% water. Example 6 is a mixed solution of 2% retinol wrap (composition of retinol wrap is 10% retinol, 40% matrine, 45% peony seed oil and 5% tocopherol) with 98% water. Example 7 is a mixed solution of 2% retinol wrap (the composition of retinol wrap is 10% retinol, 40% matrine, 45% macadamia nut oil and 5% tocopherol) with 98% water. Example 8 is a mixed solution of 2% retinol wrap (the composition of retinol wrap is 10% retinol, 40% matrine, 45% prinsepia utilis royle oil and 5% tocopherol) with 98% water. The exterior of the material bodies of examples 5 to 8 is shown in FIG. 6.
All other embodiments, which can be made by a person skilled in the art based on the embodiments of the application without any inventive effort, are intended to fall within the scope of the application.
Modifications of the technical solutions described in the above embodiments or equivalent substitutions of some technical features thereof may be made by those skilled in the art; these modifications or substitutions do not depart from the essence of the corresponding technical solutions from the protection scope of the technical solutions of the embodiments of the present application.
Claims (14)
1. A retinol wrap, characterized in that it comprises at least:
retinol;
matrine;
a solvent;
intermolecular forces exist between the retinol and matrine.
2. A retinol wrap, characterized in that it comprises at least:
retinol;
matrine;
a solvent;
the retinol wrap has at least the following hydrogen signals in the nuclear orvehaus effect spectrum:
(3.71-3.74,2.00-2.04) or (2.00-2.04,3.71-3.74);
(4.20-4.22,1.55-1.58) or (1.55-1.58,4.20-4.22);
(3.71-3.75,1.53-1.56) or (1.53-1.56,3.71-3.75).
3. The retinol wrap as defined in claim 2 wherein the retinol wrap has at least the following hydrogen signals in the nuclear euclidean effect spectrum:
(3.72-3.73,2.01-2.02) or (2.01-2.02,3.72-3.73);
(4.20-4.21,1.55-1.56) or (1.55-1.56,4.20);
(3.73-3.74,1.54-1.55) or (1.54-1.55,3.73-3.74).
4. A retinol wrap as in any one of claims 1-3 wherein the solvent is at least one of coconut oil, peony seed oil, macadamia nut oil, prinsepia utilis royle oil.
5. A retinol wrap as in any one of claims 1-3 wherein the solvent is at least one of coconut oil, prinsepia utilis royle oil.
6. A retinol wrap as in any of claims 1-3 wherein the retinol is present in an amount of 0.01-15%.
7. A retinol wrap as in any of claims 1-3 wherein the matrine is present in an amount of 25-60% and the solvent is present in an amount of 25-60%.
8. A retinol wrap as in any of claims 1-3 wherein the ratio of matrine to solvent is 1:0.5-1.5.
9. The retinol wrap as defined in claim 1, further comprising an antioxidant which is at least one of tocopherol, ascorbic acid, dibutyl hydroxy toluene.
10. Use of a retinol wrap as defined in any one of claims 1 to 9 for the preparation of cosmetics or skin care products.
11. Cosmetic raw material, characterized in that it comprises at least a retinol wrap as defined in any one of claims 1 to 9.
12. A skin preparation for external use, characterized in that it comprises at least a retinol wrap as defined in any one of claims 1 to 9.
13. A method of preparing a retinol wrap as defined in any one of claims 1 to 9, comprising the steps of:
providing retinol, matrine, a solvent and an antioxidant;
mixing, heating and stirring matrine and a solvent under a light-shielding condition and an inert atmosphere, and reacting for 2-4 hours to obtain an ionic liquid;
mixing and stirring retinol and the ionic liquid cooled to normal temperature for 2-4 hours under a light-shielding condition and an inert atmosphere to obtain a primary liquid;
mixing and stirring the antioxidant and the primary liquid for 0.5-1 h to obtain the retinol wrap.
14. The method of claim 13, wherein the solvent is at least one of coconut oil, peony seed oil, macadamia nut oil, prinsepia utilis royle oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310870369.7A CN116585217B (en) | 2023-07-17 | 2023-07-17 | Retinol wrap, raw material and external skin preparation easier to be absorbed through skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310870369.7A CN116585217B (en) | 2023-07-17 | 2023-07-17 | Retinol wrap, raw material and external skin preparation easier to be absorbed through skin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116585217A true CN116585217A (en) | 2023-08-15 |
CN116585217B CN116585217B (en) | 2024-04-16 |
Family
ID=87608308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310870369.7A Active CN116585217B (en) | 2023-07-17 | 2023-07-17 | Retinol wrap, raw material and external skin preparation easier to be absorbed through skin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116585217B (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070237837A1 (en) * | 2002-09-04 | 2007-10-11 | Biomor Israel Ltd. | Biocompatible tea tree oil compositions |
CN109575023A (en) * | 2018-12-03 | 2019-04-05 | 深圳市萱嘉生物科技有限公司 | A kind of matrine long chain fatty acids ionic liquid and the preparation method and application thereof |
CN113633562A (en) * | 2021-08-11 | 2021-11-12 | 深圳市萱嘉生物科技有限公司 | Matrine vegetable oil eutectic solvent and preparation method, application and product thereof |
CN113768806A (en) * | 2021-08-16 | 2021-12-10 | 深圳市萱嘉生物科技有限公司 | Glabridin ionic liquid nano solution and preparation method and application thereof |
CN114939079A (en) * | 2022-05-19 | 2022-08-26 | 上海奥利实业有限公司 | Preparation method and application of retinol and derivative inclusion thereof |
CN115317434A (en) * | 2022-08-22 | 2022-11-11 | 广州朵之兰投资集团有限公司 | Retinol rejuvenation essence and preparation process thereof |
CN115969737A (en) * | 2022-12-08 | 2023-04-18 | 深圳市萱嘉生物科技有限公司 | Supermolecular liposome freeze-dried mask and preparation method and application thereof |
CN116531265A (en) * | 2023-04-27 | 2023-08-04 | 深圳杉海创新技术有限公司 | Supermolecule micro-lipid capsule freeze-dried ball composition and preparation method and application thereof |
-
2023
- 2023-07-17 CN CN202310870369.7A patent/CN116585217B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070237837A1 (en) * | 2002-09-04 | 2007-10-11 | Biomor Israel Ltd. | Biocompatible tea tree oil compositions |
CN109575023A (en) * | 2018-12-03 | 2019-04-05 | 深圳市萱嘉生物科技有限公司 | A kind of matrine long chain fatty acids ionic liquid and the preparation method and application thereof |
CN113633562A (en) * | 2021-08-11 | 2021-11-12 | 深圳市萱嘉生物科技有限公司 | Matrine vegetable oil eutectic solvent and preparation method, application and product thereof |
CN113768806A (en) * | 2021-08-16 | 2021-12-10 | 深圳市萱嘉生物科技有限公司 | Glabridin ionic liquid nano solution and preparation method and application thereof |
CN114939079A (en) * | 2022-05-19 | 2022-08-26 | 上海奥利实业有限公司 | Preparation method and application of retinol and derivative inclusion thereof |
CN115317434A (en) * | 2022-08-22 | 2022-11-11 | 广州朵之兰投资集团有限公司 | Retinol rejuvenation essence and preparation process thereof |
CN115969737A (en) * | 2022-12-08 | 2023-04-18 | 深圳市萱嘉生物科技有限公司 | Supermolecular liposome freeze-dried mask and preparation method and application thereof |
CN116531265A (en) * | 2023-04-27 | 2023-08-04 | 深圳杉海创新技术有限公司 | Supermolecule micro-lipid capsule freeze-dried ball composition and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN116585217B (en) | 2024-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019469817B2 (en) | Two-dosage-form essence and preparation method therefor | |
KR102092849B1 (en) | Composition for skin whitening | |
KR20190053218A (en) | Skin care cosmetic composition | |
KR20200051997A (en) | Cosmetic Composition For Improving Wrinkle Containing Retinol, Glutathione Or Tocopherol Stabilized By Nano-Structured Lipid Carrier | |
CN104905996A (en) | Skin Lightening Compositions | |
PH12009000167A1 (en) | Stabilized Compositions Containing an Oxygen-Labile Active Agent | |
US20190110980A1 (en) | Cosmetic composition for wrinkle reduction containing gypenoside isolated from gynostemma pentaphyllum | |
US20190192417A1 (en) | Skin lightening compounds from fruit seed extracts | |
US20110318398A1 (en) | Cosmetic composition comprising molecular encapsulated fermented extract of rhus javanica l. as an active ingredient | |
CN111450003A (en) | Anti-aging and beautifying nutrient containing golden fragrant willow extract, preparation method thereof, essence and extraction method of golden fragrant willow extract | |
CN112043671A (en) | Oil-in-water hydroquinone emulsion and preparation method and application thereof | |
KR100338327B1 (en) | External application for enhancing the skin permeability of the active components therein | |
US11813348B2 (en) | Supramolecular preparation of retinol and derivatives thereof and preparation method therefor | |
JP4414495B2 (en) | Antibacterial agent, skin external preparation and skin cleansing agent containing the same | |
CN114617816A (en) | Anti-aging composition and preparation method thereof | |
CN116585217B (en) | Retinol wrap, raw material and external skin preparation easier to be absorbed through skin | |
CN116509759B (en) | Oily particle composition for coating active substance and external skin preparation | |
KR102058445B1 (en) | Cosmetics composition with Extract of Sparassis crispa Wulf. ex Fr. | |
CN111821217A (en) | Cosmetic composition, cosmetic and preparation method thereof | |
CN116637042A (en) | Wrinkle-removing anti-aging skin care product and preparation method and application thereof | |
KR101002433B1 (en) | nano-emulsion comprsing vitamine A or its derivatives and acetyl hexapeptide-3, and anti-wrinkle cosmetic preparation including the same | |
CN111658587A (en) | Collagenase inhibitor composition, anti-aging water lotion and preparation method thereof | |
EP2861208A1 (en) | Prevention of fibroblast collapse | |
CN115414293A (en) | Anti-aging composition and application thereof | |
JPH09291021A (en) | Beautifying and whitening cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |